clinical trials

Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
Flag link:
Avidity unveils positive topline data from DM1 therapy trial
Avidity unveils positive topline data from DM1 therapy trial
Clinical Trials Arena
Avidity Biosciences
AOC 1001
clinical trials
myotonic muscular dystrophy
Flag link:
Alnylam’s early Alzheimer’s results encourage, but company discloses new hurdle
Alnylam’s early Alzheimer’s results encourage, but company discloses new hurdle
BioPharma Dive
Alnylam
Regeneron
clinical trials
Alzheimer's disease
ALN-APP
Flag link:
Lilly drug Mounjaro succeeds in second weight loss study
Lilly drug Mounjaro succeeds in second weight loss study
BioPharma Dive
Eli Lilly
obesity
Mounjaro
clinical trials
Flag link:
AstraZeneca dumps $855M, near-approval rare disease drug after talks with regulators
AstraZeneca dumps $855M, near-approval rare disease drug after talks with regulators
Fierce Biotech
AstraZeneca
clinical trials
ALXN1840
Wilson disease
Flag link:
Novartis’s iptacopan meets primary endpoint in Phase III PNH trial
Novartis’s iptacopan meets primary endpoint in Phase III PNH trial
Clinical Trials Arena
Novartis
clinical trials
PNH
iptacopan
Flag link:
ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy
ALX and Sanofi partner to start Phase l/ll trial of RRMM combo therapy
Clinical Trials Arena
ALX Oncology
Sanofi
clinical trials
evorpacept
Sarclisa
relapsed or refractory multiple myeloma
Flag link:
Emerald trial gleams for Morphic
Emerald trial gleams for Morphic
EP Vantage
Morphic Therapeutic
clinical trials
ulcerative colitis
MORF-057
Flag link:
After 20-month hold, FDA drops resistance to fecal pooling, clears MaaT to run pivotal trial
After 20-month hold, FDA drops resistance to fecal pooling, clears MaaT to run pivotal trial
Fierce Biotech
MaaT Pharma
FDA
clinical trials
fecal therapy
graft vs host disease
Flag link:
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Cytokinetics
clinical trials
ALS
reldesemtiv
cardiomyopathy
aficamten
Flag link:
In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy
In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy
Fierce Pharma
Eli Lilly
clinical trials
obesity
Mounjaro
Novo Nordisk
Wegovy
Flag link:
Apellis’ immune system drug hits a setback in ALS
Apellis’ immune system drug hits a setback in ALS
BioPharma Dive
Apellis Pharmaceuticals
clinical trials
ALS
pegcetacoplan
Flag link:
FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101
FDA clears Sensei’s IND to start Phase I/II therapy trial of SNS-101
Clinical Trials Arena
Sensei Biotherapeutics
SNS-101
clinical trials
solid tumors
Flag link:
BeiGene's gastric cancer drug succeeds in late-stage trial
BeiGene's gastric cancer drug succeeds in late-stage trial
Reuters
BeiGene
gastric cancer
clinical trials
tislelizumab
Flag link:
Vaxcyte Up on Pneumococcal Conjugate Vaccine Data
Vaxcyte Up on Pneumococcal Conjugate Vaccine Data
Zacks.com
Vaxcyte
vaccines
clinical trials
pneumococcal disease
VAX-24
Flag link:
Revolo drops dab of midphase data on would-be Dupixent rival
Revolo drops dab of midphase data on would-be Dupixent rival
Fierce Biotech
Revolo Biotherapeutics
clinical trials
allergies
Dupixent
Flag link:
MinervaX initiates Phase I GBS vaccine trial in older people
MinervaX initiates Phase I GBS vaccine trial in older people
Clinical Trials Arena
Minervax
clinical trials
group B
vaccines
Flag link:
Vaxcyte strengthens case for experimental pneumococcal vaccine
Vaxcyte strengthens case for experimental pneumococcal vaccine
BioPharma Dive
Vaxcyte
vaccines
clinical trials
pneumococcal disease
Flag link:
Inovio reports new data for Ebola booster vaccine
Inovio reports new data for Ebola booster vaccine
Clinical Trials Arena
Inovio
vaccines
clinical trials
ebola virus
Flag link:
Moderna & Merck plan Phase 3 trial for cancer vaccine with Keytruda
Moderna & Merck plan Phase 3 trial for cancer vaccine with Keytruda
Biopharma Reporter
Merck
Moderna Therapeutics
cancer
cancer vaccines
Keytruda
clinical trials
Flag link:

Pages